HomeNewsIndiaFrom early graduation to flexible grading, IITs chalk out plan for graduating students amid lockdown

From early graduation to flexible grading, IITs chalk out plan for graduating students amid lockdown

Universities and schools across the country have been closed since March 16 when the Centre announced a nationwide classroom shutdown as part of a slew of measures to contain the COVID-19 outbreak.

June 02, 2020 / 20:36 IST
Story continues below Advertisement

Early graduation, flexible grading system, option to appear for exams later and no termination are among the alternatives being offered by the Indian Institutes of Technology (IITs) for their graduating students to ensure their future plans are not affected due to the COVID-19 lockdown.

IIT-Delhi is giving two options to its graduating batch - those who have less than a semester left to graduate, can decide to either go for an "early graduation" option, happening in June-end, or go through a "regular graduation process", which will happen as and when the institute reopens.

Story continues below Advertisement

"For the early graduation option too, we are offering two choices to students-- an 'audit pass or fail' option or a 'credit' option. While the former will allow students to use their previous grades for assessment, for the latter students will have to take online tests, home exams, assignments, telephone viva, among others," IIT Delhi Director V Ramgopal said.

IIT Roorkee has come up with a one-time special provision in which the performance of the students in spring semester 2019-2020 would not be counted for academic performance-based termination of programs, slow pace programs, and towards any other such clauses.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show